Skip to main content

Tempest Therapeutics shares end wild week with 8% drop

Oncology company adopted poison pill to address "dislocation" in its stock price.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.